
Dr Peta-Lee Sacks
Rhinology, sinus surgery and anterior skull base surgery. BMed, MD, PhD, FRACS
Dr Peta-Lee Sacks is a rhinologist and anterior skull base surgeon. She completed her medical degrees (BMed, MD) at UNSW and is a Fellow of the Royal Australasian College of Surgeons in Otolaryngology, Head and Neck Surgery. She holds a PhD in Surgery from UNSW; her doctoral research examined actionable mutations and prognostic biomarkers in sinonasal cancers.
After specialist training she undertook advanced fellowship training in rhinology and skull base surgery at St Vincent’s Hospital and Macquarie University Hospital in Sydney with Professor Richard Harvey, and at Guy’s and St Thomas’ NHS Foundation Trust in London with Professor Claire Hopkins.
Her practice covers chronic rhinosinusitis and nasal polyps, including biologic therapy, nasal obstruction, septoplasty and functional rhinoplasty, endoscopic and revision sinus surgery, endoscopic pituitary surgery, and surgery for sinonasal and anterior skull base tumours. She operates at St Vincent’s Public and Private Hospitals, Macquarie University Hospital and St George Private Hospital. She co-leads the Rhinology and Skull Base Service with Professor Harvey.
Dr Sacks has authored more than 25 peer-reviewed papers and book chapters on chronic rhinosinusitis, sinonasal malignancy, paranasal sinus radiomics and rhinoplasty outcomes, presents at national and international meetings, and serves on the editorial board of the Australian Journal of Otolaryngology.
At St Vincent’s
Public clinics through St Vincent’s Hospital ENT outpatients; referrals through the St Vincent’s Hospital ENT page.
Private rooms
67 Burton Street, Darlinghurst NSW 2010; Blue Shield Specialist Medical Centre, Suite 5, Level 2, 19 Kensington Street, Kogarah NSW 2217
Tel +61 2 9101 2530 · psreception@sydneyentclinic.com
Selected publications
- Sacks PL, Meerwein CM, Earls P et al. Persistent Eosinophilic Inflammation Is Not a Feature of Type 2 CRS Patients Failing Anti-IL-5R Therapy and Requiring Class Switching to Anti-IL-4/13. Int Forum Allergy Rhinol 2025;15(6):602-607. doi
- Campion NJ, Sacks PL, Png LH et al. Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS. Int Forum Allergy Rhinol 2026;16(9):986-995. doi
- Sacks PL, Alvarado R, Sacks R et al. Prognostic factors and outcomes in minimal access resections of skull base and sinonasal epithelial malignancy. ANZ J Surg 2022;92(12):3253-3258. doi
- Darbari Kaul R, Sacks PL, Thiel C et al. Radiomics of the Paranasal Sinuses: A Systematic Review of Computer-Assisted Techniques to Assess Computed Tomography Radiological Data. Am J Rhinol Allergy 2025;39(2):147-158. doi
- Meerwein CM, Sacks PL, Ho J et al. The effect of allergen immunotherapy in patients with central compartment atopic disease post-surgery. Int Forum Allergy Rhinol 2025;15(2):128-134. doi
- Hocknell E, Sacks PL, Vamadevan U et al. Improving prescriber confidence in COX-2 inhibitor use for aspirin-exacerbated respiratory disease: impact of a standard operating procedure. Front Allergy 2026;7:1854011. doi
- Sacks PL, Snidvongs K, Rom D et al. The impact of neo-osteogenesis on disease control in chronic rhinosinusitis after primary surgery. Int Forum Allergy Rhinol 2013;3(10):823-7. doi
- Rom D, Snidvongs K, Sacks PL et al. The impact of culturable bacterial community on histopathology in chronic rhinosinusitis. Int Forum Allergy Rhinol 2014;4(1):29-33. doi
- Sacks PL 4th, Harvey RJ, Rimmer J et al. Antifungal therapy in the treatment of chronic rhinosinusitis: a meta-analysis. Am J Rhinol Allergy 2012;26(2):141-7. doi
- Sacks PL, Harvey RJ, Rimmer J et al. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev 2011(8):CD008263. doi
